Sumatriptan Induced Brugada Syndrome, a Rare Presentation of a Commonly Used Drug

Authors

• Phool Iqbal, New York Medical College
• Saba Nabavi Monfared
• Daniel Hernan Sacoto, New York Medical College
• Mustafa Bilal Ozbay, New York Medical College
• Wael Abdelmottaleb, New York Medical College
• Valentina Turbay Caballero
• Muhammad Kalid Tahir, New York Medical College
• Savi Mushiyev, New York Medical College

Author Type(s)

Resident/Fellow, Faculty

DOI

10.1002/ccr3.70417

Journal Title

Clinical Case Reports

First Page

70417

Last Page

70417

Document Type

Article

Publication Date

6-3-2025

Department

Medicine

Keywords

arrhythmia; Brugada syndrome; migraine headaches; sumatriptan

Disciplines

Medicine and Health Sciences

Abstract

We aim to highlight an important and rare association of Brugada Syndrome with a commonly used medication, Sumatriptan, which is used as an aborting Migraine headaches. This life-threatening condition needs early diagnosis and prompt management with vigilant follow-up for better patient outcomes.

Recommended Citation

Iqbal, P., Monfared, S., Sacoto, D. H., Ozbay, M., Abdelmottaleb, W., Caballero, V., Tahir, M. K., & Mushiyev, S. (2025). Sumatriptan Induced Brugada Syndrome, a Rare Presentation of a Commonly Used Drug. Clinical Case Reports, 13 (6), 70417-70417. https://doi.org/10.1002/ccr3.70417